2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Ovarian Neoplasms
104
Breast Neoplasms
76
Fallopian Tube Neoplasms
47
Multiple Myeloma
32
Carcinoma, Ovarian Epithelial
27
Neoplasms
23
Lymphoma
16
Sarcoma
13
Triple Negative Breast Neoplasms
12
Recurrence
12
Neoplasm Metastasis
12
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Non-Hodgkin
8
Hodgkin Disease
8
Neoplasms, Plasma Cell
6
Prostatic Neoplasms
5
Burkitt Lymphoma
5
Solid Tumors
4
Sarcoma, Kaposi
4
Sarcoma, Ewing
4
Pancreatic Neoplasms
4
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Mantle-Cell
4
Leiomyosarcoma
4
Endometrial Neoplasms
4
Carcinoma
4
Breast Neoplasms, Male
4
Uterine Cervical Neoplasms
3
Rhabdomyosarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
Antineoplastic Agents
3
Nutrition Assessment
2
Mass Screening
2
Echocardiography
2
Blood Specimen Collection
2
liposomal doxorubicin
1
Vitamin E
1
Vitamin D
1
Vital Signs
1
Tomography, X-Ray Computed
1
Tomography, Emission-Computed
1
Therapeutics
1
Surveys and Questionnaires
1
Specimen Handling
1
Progestins
1
Positron-Emission Tomography
1
Methods
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Immunomodulating Agents
1
Immune Checkpoint Inhibitors
1
Hormone Replacement Therapy
1
Hematologic Tests
1
Exercise Test
1
Estrogens
1
Estrogen Replacement Therapy
1
Educational Status
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Diagnosis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Heart Diseases
×
liposomal doxorubicin
×
Clear all
NCT00563953
2017-10-12
CAPRICE
SOLTI Breast Cancer Research Group
Phase 2
Completed
50 enrolled